Gold House Ventures
Gold House Ventures focuses on investing in early-stage (pre-seed to Series A) startups founded by Asian Pacific entrepreneurs or those significantly supporting the Asian Pacific community, primarily within high-growth consumer and technology sectors. Their strategy involves leveraging the extensive Gold House network to provide portfolio companies with strategic support and connections, operating with an "affinity-based, returns-driven model" that also generates funding for the Gold House non-profit.
30% of their portfolio is in Fintech. They made 1 investments in the last 12 months. Their most common stage is seed (40% of deals). Average disclosed round size is $34.2M (across 10 rounds with reported amounts).
Portfolio
10
Fund Size
$30M
Top Stage
Seed
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 MedSetGo | Seed | $2.4M | Sep 2025 |
 Glencoco | Seed | $3M | Nov 2023 |
 Anise Health | Pre-Seed | $1.2M | Jun 2023 |
 Xiao Chi Jie | Series A | $10M | Oct 2022 |
 Nitra | Seed | $62M | Aug 2022 |
| TTomoCredit | Growth | $122M | Jul 2022 |
 Super | Series C | $70M | Jun 2022 |
 Sanzo | Series A | $10M | Feb 2022 |
 Pluang | Series B | $55M | Jan 2022 |
 Umamicart | Seed | $6M | Dec 2021 |
Top Co-Investors
Last updated: 16 April 2026